High-Volume Hospitals’ Ovarian Cancer Care—Less Individual Approach or Better Treatment Results?

• Published in: Current oncology (Toronto) 2022-07, Vol.29 (8), p.5278-5294
• Main Authors: Millert-Kalińska, Sonja, Pruski, Dominik, Przybylski, Marcin, Stawicka-Niełacna, Małgorzata, Mądry, Edyta, Mądry, Radosław
• Format: Article
• Language: English
• Subjects: Cancer; Care and treatment; epithelial ovarian cancer; high-volume hospital; laparoscopy in oncology; oncological units; Oncology, Experimental; Ovarian cancer
• ISSN: 1718-7729; 1198-0052; 1718-7729
• DOI: 10.3390/curroncol29080419

Ovarian cancer (OC) is the eighth most common cancer worldwide and is usually diagnosed in advanced stages. The relationship between treatment in high-volume hospitals (HVHs) and survival in OC has been documented by multiple studies, which showed that superior treatment and survival outcomes are associated with surgical expertise and multidisciplinary resources. To our study, 135 first-time patients treated in the years 2019–2020 in the Department of Oncology of Poznań University of Medical Sciences were enrolled. Th analysis showed a significant dependency between being treated in a HVH from the beginning of one’s diagnosis and the scope of the first intervention. Additionally, among patients treated in our centre, a significant portion of patients underwent laparoscopy, and from one year to another the number of laparoscopies performed increased. This may indicate that more patients began to qualify for neoadjuvant treatment. Patients benefit the most from surgery in a centre with more experience in treating ovarian cancer. In the future, we will be able to expand this study by using data from patients treated before 2019 and analysing larger cohorts of patients. This might enable us to update the rates of overall survival (OS), objective response rate (ORR) and progression-free survival (PFS).